The impact of ageing in people with intellectual and developmental disability by Glasson, E. & Bittles, A.H.
BIENNIAL BOOKS OF EAA, 2008, Vol. 5. 1−17. 
 
 
 
The Impact of Ageing in People with Intellectual 
and Developmental Disability 
Emma J. Glasson
1,2 and Alan H. Bittles
1,3
1School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Australia 
2School of Population Health, The University of Western Australia, Australia 
3Centre for Comparative Genomics, Murdoch University, Perth, Australia 
 
 
 
Summary: In the countries of Western Europe, death rates declined rapidly during the 20th 
century, resulting in present-day life expectancies that range from 75–79 years for males 
and 80–84 years for females.  Premature mortality among people with intellectual and 
developmental disability (IDD) also decreased very significantly, especially over the course 
of last 50 years, with the result that life expectancy estimates are now over 70 years for 
people with mild IDD and 60 years for those with severe levels of IDD. The pattern of 
increasing survival of people with IDD means that in future years they almost inevitably 
will be at greater risk of age-related ill-health.  There are many disorders that arise later in 
adulthood which commonly affect those with IDD, such as obesity, osteoporosis, epilepsy, 
cardiovascular disease, and dementia.  Generally, the age-related ill-health experienced by 
people with IDD occurs at younger ages than in the general population, and greater focus is 
needed on disorders which emerge during middle age to senescence so that appropriate 
management regimes can be implemented.  These are important considerations in terms of 
the types and continuity of care to be made available, especially since many people with 
IDD already outlive their parents and other family members. 
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Introduction 
Intellectual and developmental disability (IDD) is formally defined in terms of 
significant limitations in intellectual functioning and adaptive behaviour, as 
expressed conceptually, socially and practically, with onset before 18 years of age 
(AAIDD 2002).  A diagnosis of IDD is made when scores obtained on standardized 
IQ and adaptive behaviour tests are more than two standard deviations below the 
mean (i.e., less than 70 points).  As indicated in Table 1, the level of disability 
experienced by an individual is categorized by the absolute scores obtained on both 
of these tests.  Individuals with a mild level of disability (IQ 55–69) form the largest 
sub-group, representing some 85% of all people with IDD, whereas approximately 
10% of cases have moderate disability (IQ 40–54) and 5% have severe disability  
(IQ <40) (APA 1994).  E. J. Glasson and A. H. Bittles 
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Table 1:  Levels of intellectual and developmental disability (IDD) by practical abilities. 
IQ/Adaptive 
behaviour score
Descriptive level 
of IDD 
Functional age 
equivalence 
Expected abilities 
90–110 Average   
 
 
 
85–89 Low  average  
 
 
70–84 Borderline   
 
 
55–69 Mild  9–12 years  Developmental  milestones often delayed. 
Learning difficulties displayed but can learn 
practical skills.  Usually able to work, 
contribute to society and maintain good 
social relationships. 
40–54 Moderate  6–9  years Noticeable developmental delays are 
common and physical disabilities probable. 
May learn independence in self-care and 
communication.  Need support to live and 
work in the general community. 
<40 Severe  <6 years 
 
Marked and obvious developmental delays. 
Few communication skills present.  May 
learn routine or repetitive tasks.  Continuous 
support needed in all areas of living. 
 
An estimated 0.6–2.0% of people in developed countries have some form of IDD 
(Roeleveld et al. 1997, WHO 2001, AIHW 2003, Walsh et al. 2003), with 0.5–1.0% 
requiring daily support because of their disability (AIHW 2003).  Determining the 
exact population prevalence of IDD is difficult because: i) people with IDD have 
high rates of premature mortality; ii) variations exist in the methods of case 
ascertainment, which may be exacerbated by incomplete psychological testing; and 
iii) individuals who develop good adaptive behaviour skills may exceed the 
minimum definition of IDD in their adult years (AIHW 2003).  It is even more 
difficult to calculate prevalence rates of IDD in developing countries, but estimates 
have ranged from 3.0–8.4% (Durkin et al. 1998, Christianson et al. 2002, Durkin 
2002), with poor living conditions, inadequate diet and high rates of endogamy and 
consanguineous marriage in some regions cited as important contributory factors 
(Bittles and Glasson, in press). 
Increases in life expectancy 
The overall health of people in developed regions increased significantly during 
the 20th century due to a combination of advances in medicine, better health care 
resources and treatments, and improvements in lifestyle, housing and nutrition (CDC 
1999, Bittles and Glasson, in press).  In countries such as Australia these advances 
were reflected by reductions in infant mortality rates (i.e., death up to one year of Ageing in people with intellectual disability 
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age) from 107 to 5 per 1,000 births between 1902 and 2002 (ABS 2004), and 
improvements in life expectancy from 55 to 76 years for males and 59 to 82 years 
for females (ABS 2002).  In the U.S.A., life expectancy increased by 30 years over 
the past century, of which 25 years were attributed to advances in public health 
(CDC 1999).  Similarly, in Western European countries, current life expectancy 
ranges from 75–79 years for males and 80–84 years for females (PRB 2006), and 
country-specific data from the European Commission-funded Healthy Ageing 
Project indicate that 2.3–5.3% of all Europeans are over 80 years of age (SNIPH 
2007). 
In earlier times people with IDD were subject to major discrimination and from 
the late 19th century until the 1960s children and young adults with IDD could be 
sterilized in many parts of North America and Europe, while in Nazi Germany 
euthanasia was legally permissible for those with IDD between 1939 and 1945 
(Bittles and Chew 1998).  More recently there has been a major change in public 
attitudes to IDD, with greater acceptance that people with intellectual disabilities 
should be enabled to live independently in the community and be integrated into the 
education sector and workforce. 
The gradual closure of large institutions caring for people with IDD, and the 
introduction of smaller, better-resourced centres with trained health care workers and 
specialised care regimes, has greatly assisted in improving their overall health and 
life expectancy (Bittles and Glasson, in press).  By the end of the 20th century in 
most developed countries, survival estimates for those with IDD were approaching 
the levels in the general population, with estimates of 70 or more years of age for 
people with mild IDD and 60 years for those with severe levels of IDD (Janicki et al. 
1999, Bittles et al. 2002).  This trend is illustrated by data from Western Australia, 
based on a study sample of 8,274 people with IDD investigated via record linkage of 
population-based health data sets (Bittles et al. 2002).  As shown in Table 2, life 
expectancy was inversely related to the severity of IDD and, as in the general 
population, the median life expectancy of women was greater than men at all levels 
of IDD. 
 
Table 2:  Median life expectancy by level of IDD and gender*. 
Level of IDD  Male median life expectancy 
(yr)  
Female median life expectancy 
(yr) 
Mild 72.8  75.2 
Moderate 65.9  73.2 
Severe 57.6  60.3 
*Based on a sample of 8,274 people with IDD in Western Australian (Bittles et al. 2002). 
 
There also have been increased opportunities for people with IDD to contribute 
more widely to social, sporting and economic roles (Carek et al. 2002), although 
continuing progress is needed to ensure equality in the community, especially in 
health care (Mencap 1998, Hogg et al. 2001, US Public Health Service 2001, 
Mansell 2006).  Within Europe, thirteen member countries of the European Union E. J. Glasson and A. H. Bittles 
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are involved in the Pamona project, which aims to develop a set of health guidelines 
based on the European Community Health Indicators, to eliminate disparities in 
health, and improve the quality of life and health equity for people with IDD (Walsh 
et al. 2003). 
Down syndrome and ageing 
Down syndrome is the most commonly recognized genetic form of IDD and has 
been the subject of extensive research since its initial description by Dr. James 
Langdon Down in 1866.  In developed countries, Down syndrome accounts for 12–
15% of all cases of IDD (Wellesley et al. 1991, Alessandri et al. 1996, Hou et al. 
1998, Bittles et al. 2002), with 1 in 650–1000 live births affected with the disorder 
(Baird and Sadovnick 1987, Stoll et al. 1998, Frid et al. 1999).  Globally, it has been 
estimated that some 217,000 cases of Down syndrome are born per year (March of 
Dimes 2006).  Despite the availability of prenatal testing and the option of 
termination of affected pregnancies, the number of Down syndrome live births has 
remained constant or even increased within Europe and in other developed regions 
over the last generation, primarily due to an overall increase in mean maternal age 
(Nicholson and Alberman 1992, O'Leary et al. 1996, Binkert et al. 2002, Dolk et al. 
2005, Metneki and Czeizel 2005, Crane and Morris 2006). 
Since the 1950s the survival of people with Down syndrome in Western countries 
has improved in response to better health care opportunities, with an increase in life 
expectancy of just over one year for each calendar year to almost 60 years by the end 
of the century (Bittles and Glasson 2004).  In contrast to the general situation of 
higher female life expectancy among people with IDD (Table 2), males with Down 
syndrome have a significantly greater median life expectancy than females (Glasson 
et al. 2003).  The survival disadvantage of women with Down syndrome is possibly 
related to interaction between pre-existing cardiac defects that are more common in 
females with the disorder and changes in oestrogen levels following menopause, the 
onset of which usually is observed at a comparatively young age. 
The health status of people with intellectual and  
developmental disabilities 
People with IDD vary widely in terms of their IDD aetiology, clinical profile, 
degree of impairment and support needs.  The care of each individual with IDD is 
unique and often complex, and health concerns may be compounded by 
communication difficulties when there is dependence on others for monitoring and 
responding to needs.  In general terms, people with IDD experience poorer health 
than the general population and they encounter greater barriers in accessing health 
care (Walsh et al. 2003).  They also are less likely to participate in health screening 
programmes or to undergo regular medical checks (Sullivan et al. 2003, Owens et al. 
2006).  Furthermore, factors such as limited social networks, poor self-esteem and 
limited supports for life stresses may contribute to the health disparities associated Ageing in people with intellectual disability 
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with such a vulnerable population (Walsh et al. 2003).  Education and awareness is 
necessary for carers and the professional health community so that they can 
effectively and proactively monitor patterns of ill-health arising with age, and be 
aware of syndrome-specific health concerns (WHO 2000). 
Childhood and young adulthood 
For many people with IDD, specific conditions are present at birth or develop in 
early childhood.  Congenital heart defects have been reported in 42%–60% of 
children with Down syndrome (Tubman et al. 1991, Wells et al. 1994, Venugopalan 
and Agarwal 2003, Vida et al. 2005), and their incidence of childhood leukaemia is 
more than 20 times higher than the comparable general population (Fong and 
Brodeur 1987, Hasle et al. 2000, Chessells et al. 2001, Hogg et al. 2001, Hill et al. 
2003, Goldacre et al. 2004, Sullivan et al. 2007).  Other syndromes with specific 
health conditions need to be monitored from an early age.  For example, disorders of 
the thyroid gland are common in children with Williams syndrome (Selicorni et al. 
2006), seizures have a high prevalence in children with Angelman syndrome 
(Guerrini et al. 2003), and scoliosis affects a large proportion of young women with 
Rett syndrome (Kerr et al. 2003b). 
Children with IDD more commonly require hospitalization for infections and 
gastrointestinal illness, as well as central nervous system and mental health problems 
(Williams et al. 2005).  Despite their greater need for specialist care, the diagnosis 
and treatment of health disorders for children and adults with IDD are often poorly 
managed within health care systems that are primarily designed for the mainstream 
public (Krahn et al. 2006).  Care is often complicated by special needs and multiple 
ailments and, as previously noted, it also may be hampered by communication 
difficulties and the presence of behavioural problems in patients (Millar et al. 2004).  
For this reason, substantial parental or caregiver assistance may be required to ensure 
that patients’ health care needs are properly met (Iacono and Davis 2003a, Iacono 
and Davis 2003b). 
The biological impact of ageing in people with IDD 
Age-related conditions experienced by people with IDD usually commence at 
younger ages than in the general population, and they can progress rapidly in a 
poorly managed environment or if the problems are not communicated to carers.  As 
with older people in general, individuals with IDD may be at increased risk of 
polypharmacy, i.e., the prescription of multiple medications for one or several 
disorders.  In such instances, serious behavioural side-effects and adverse health 
outcomes can result (WHO 2000). 
Sensory impairments are more common in people with IDD and these problems 
can develop more frequently with advancing age and as comorbidities of specific 
syndromes.  Visual impairment is more common in older and more severely disabled 
persons (Owens et al. 2006), and in conditions such as Down syndrome.  Age-related 
hearing loss in people with Down syndrome also is observed some three decades 
earlier than expected and it is thought to affect all adults with Down syndrome over 
the age of 60 years (Meuwese-Jongejeugd et al. 2006).  In general terms, hearing E. J. Glasson and A. H. Bittles 
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loss may be 40–100 times more prevalent in people with IDD than in the wider 
population (Carvill 2001), but conductive hearing loss or impacted ear wax may 
remain undiagnosed or be underestimated without regular testing (Evenhuis 1996, 
Carvill 2001, Kerr et al. 2003a). 
Although poor oral health is widespread among people with IDD (Owens et al. 
2006), behavioural or physical barriers frequently prevent them from undergoing 
routine procedures without general anaesthesia and hospitalization.  Obesity 
(Rimmer and Yamaki 2006), dementia (Janicki and Dalton 2000), and 
cardiovascular disease (van den Akker et al. 2006) all usually increase in prevalence 
during adulthood and can pose additional health issues with advancing age.  The risk 
of osteoporosis increases with age, especially among females, individuals with 
severe immobility, or those prescribed long-term anti-convulsant medications (Jaffe 
et al. 2005). 
General psychiatric morbidity, including emotional and/or behavioural problems, 
are thought to affect around 40% of people with IDD, approximately three times the 
rate observed in the general population (Emerson 2003).  Major psychotic disorders 
have been identified in up to 15% of people with IDD (Stromme and Diseth 2000, 
Gustavson et al. 2005), including conditions such as schizophrenia, clinical 
depression, maladaptive disorders, pervasive developmental disorders and 
behavioural abnormalities.  These disorders occur as part of the known phenotype of 
specific syndromes causing IDD, with clinical dementia often diagnosed in older 
people with Down syndrome (Coppus et al. 2006), autism more prevalent in people 
with Fragile X syndrome (Hatton et al. 2006), and eating disorders, self-injury and 
obsessive compulsive disorders common among children and adults with the 
epigenetic disorder Prader-Willi syndrome (Dykens et al. 1996, Hartley et al. 2005, 
Thomson et al. 2006). 
The prevalence of cancer in people with IDD is comparable to levels reported in 
the general population (Patja et al. 2001, Sullivan et al. 2004), but with some 
differences observed across populations by age, severity of IDD and gender.  On a 
gender-specific basis, testicular cancer, brain and stomach cancers are increased in 
males with IDD, with an increased prevalence of ovarian and uterine cancers and 
colorectal cancer in females (Sullivan et al. 2004).  In the specific example of Down 
syndrome, higher overall rates of pancreatic, skin cancers, retinoblastoma, and 
malignant tumours of the brain have been observed (Hasle et al. 2000, Patja et al. 
2001).  Conversely, lower rates of breast cancer were reported among women of 
reproductive and post-reproductive age with Down syndrome (Hasle et al. 2000), 
although this finding may in part reflect poorer uptake of breast screening and hence 
breast cancer diagnosis (Piachaud and Rohde 1998, Sullivan et al. 2003).  As 
indicated by the life expectancies listed in Table 2, women with all forms of IDD are 
surviving to ages where the incidence of breast cancer increases sharply, and so the 
implementation of good practice guidelines for breast and cervical cancer screening 
is a matter of increasing importance (NHSCSP 2000). Ageing in people with intellectual disability 
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Psychological, social and emotional changes with ageing 
The psychological and social life stages that characterize adulthood in the general 
community have been poorly researched in the IDD population.  Issues surrounding 
irregular employment and retirement from paid or voluntary work at older ages need 
further investigation (Ashman et al. 1995), mainly because of their potential 
psychological impact and resulting quality of life (Rogers et al. 1998, Esbensen and 
Benson 2006).  Loneliness and depression can occur in people with IDD who lose 
existing friends and fail to develop new friendships, and whose limited social 
networks may result in excessive unstructured free time (Duvdevany and Arar 2004).  
Behavioural disturbance and emotional distress has been reported in people with 
IDD following the death of a parent, but these conditions may largely go 
unrecognized.  Specialised counselling and coping strategies for bereavement can 
have positive effects (Dowling et al. 2006), however, further research is needed into 
related subjects such as pain recognition, palliative care, and general end-of-life 
support mechanisms (Tuffrey-Wijne 2003). 
It is now accepted that adults with IDD, especially those who are mildly affected, 
express a need for romantic and sexual relationships, but they also may have a very 
limited knowledge of sexual issues (Elkins et al. 1990, Siebelink et al. 2006).  Under 
certain circumstances parenthood is regarded as an emerging right for people with 
IDD, but the situation is made more complex by the levels of support required 
(Kandel et al. 2005).  Further biological research and  improved education and 
advice on sexuality issues is therefore needed (WHO 2000), including an 
understanding of the physical signs and effects of menarche and menopause, and 
access to contraceptive advice where desired. 
Meeting the future needs of older people with intellectual and  
developmental disability 
As identified in the Healthy Ageing Project sponsored by the European 
Commission and the World Health Organization (SNIPH 2007), improved care and 
interventions have enhanced overall community health, resulting in more people 
living longer lives albeit with greater risks of ill-health.  The survival of people with 
IDD to more advanced ages will result in greater numbers living in the community, 
but with increased demands for specialist care given the particular patterns of 
comorbidity that can arise at certain life stages (Bittles et al. 2007).  Greater focus is 
needed on disorders which are diagnosed during middle age to senescence so that 
appropriate management regimes can be implemented.  In particular, more detailed 
investigations are needed to ascertain the pattern of specific age-related problems in 
particular syndromes and the influence of environmental factors, including diet and 
exercise, on these emergent problems. The World Health Organization has E. J. Glasson and A. H. Bittles 
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recommended that health care providers adopt a total lifespan approach to meeting 
the health needs of people with IDD, which recognizes the progression of specific 
diseases and the requirement for appropriate therapeutic interventions (WHO 2000).  
With this in mind, a number of priority areas that have been identified in the 
literature to improve and sustain good health outcomes for people with IDD are 
presented in Table 3. 
 
 
Table 3:  Priority areas of age-related research and care for people with IDD. 
•  More health care professionals trained in caring for people with IDD 
•  Provision of ‘case managers’ to liaise between people with IDD and their health 
care providers 
•  Remodelling of community resources and current systems to better 
accommodate the individual needs of those with IDD 
•  More numerous, well-equipped residential facilities, including short-term respite 
centres for patients and/or their carers 
•  Better education of all health practitioners through the wider publication of 
information in general medical and health journals 
•  Regular screening of expected health concerns at ages that are relevant to people 
with IDD 
•  Active targeting of people with IDD and their carers in public education 
campaigns 
•  Encouragement of long-term friendships and social support for people with IDD 
•  Increased education and support in issues of sexuality 
•  Greater understanding of, and direct assistance with, bereavement and palliative 
care needs 
 
 
In most developed countries, the majority of people with IDD can experience an 
independent or partially independent lifestyle within the wider population.  This 
trend is continuing and, for example, in 2007 the U.K. National Health Service 
announced plans to relocate some 2,000 people with IDD from former hospital 
accommodation into community homes by 2010.  While progress in this area is 
welcome, several potential disadvantages still need to be addressed.  Major concerns 
include the quality and accessibility of care available to people with IDD living in 
the community, and also the implementation of support structures to help people 
with IDD seek and maintain good health on their own behalf.  In the absence of the 
structured lifestyle regimes commonly associated with institutional settings, a 
negative impact on health may result with the risk of reduced access to trained and 
experienced health professionals and fewer regular health checks (Nottestad and 
Linaker 1999, Dovey and Webb 2000). People with IDD generally place greater 
demands on the consultation time of medical practitioners (Straetmans et al. 2007), 
and due to a lack of relevant experience, medical practitioners serving the general Ageing in people with intellectual disability 
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population may have difficulty in adequately diagnosing and treating people with 
IDD. 
Other consequences of community living include the potential to develop 
lifestyle diseases, such as obesity, diabetes, blood pressure anomalies and 
cardiovascular illness, and to engage in risk-taking behaviour, including smoking 
and substance abuse.  Increased exposure to undesirable lifestyle choices may 
explain the higher levels of obesity in people living either in community-based 
residential homes, or with family members, by comparison with institutional settings 
(Rimmer and Yamaki 2006).  The overall success of community-based living in 
terms of levels of health, behaviour and overall satisfaction is often related to the 
quality of care received and management expertise, rather than dwelling size 
(Mansell 2006). 
Economic perspectives 
At least 9% of disease-specific healthcare costs in The Netherlands were found to 
be devoted to the needs of people with IDD (Polder et al. 2002), and these costs 
predictably will expand to a significant degree if age-related disorders such as 
dementia and cancer increase in prevalence.  The total lifetime costs for people with 
IDD born in the U.S.A. in the year 2000 were estimated to be US$51.2 billion, with 
approximately US$12 billion attributable to direct care and health costs (CDC 2004).  
Both the Dutch and U.S. data therefore reinforce the need for more efficient 
prevention programmes, to minimize the adverse impact of IDD through primary 
care interventions, and to develop schemes that will enable people with IDD to live 
productively and with personal satisfaction within the community. 
The ageing carers of people with IDD 
The levels of stress associated with care provision for people with IDD can 
greatly exceed those experienced with other categories of dependent persons, in large 
part because of the additional health disorders that need to be monitored and treated 
(Roach et al. 1999, Canadian Study of Health and Aging Working Group 2002, 
Hedov et al. 2002, Rymer et al. 2002, Raina et al. 2005, White et al. 2006).   
Premature ageing at the cellular level has been observed in women caring for 
chronically ill children (Epel et al. 2004), which may have implications with respect 
to the availability of health and life insurance cover for carers in countries where 
such services are not provided by government agencies (Thomson et al. 2006).   
However, the exact nature of the stress interactions and their long-term physiological 
impact remain to be fully assessed.  As yet, little progress has been made in 
investigating the health impact of caring for ageing people with disorders such as 
Down syndrome in whom, as previously described, dementia may develop in early 
adulthood and require specialist care for the remaining years of their life.  These are 
very important considerations in terms of the types and continuity of care since, 
given the trend towards pregnancies at older maternal ages, a person with Down 
syndrome or other forms of IDD will probably outlive their parents, siblings and 
other relatives. E. J. Glasson and A. H. Bittles 
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Ethical considerations 
Many ethical issues of a medical or social nature have begun to emerge because 
of the rapidly increasing life expectancies of people with IDD, and these issues 
frequently are associated with the right to exercise greater control of their own 
destiny.  Decision-making, including residence in a setting appropriate to their 
needs, their choice of employment, and the ability to choose their own leisure 
activities, may become more complex for adults with IDD where family members or 
carers formerly had acted on their behalf (Wong et al. 1999). 
Examples of medical care situations that may be affected include the potential 
role of people with IDD as organ recipients or donors, access to medical procedures 
and priority status on waiting lists, and the provision of informed consent for 
treatment.  In the past, IDD was usually considered an absolute contra-indication for 
patients to be accepted for major organ transplantation, on the grounds of 
compliance with medical regimes and quality of life issues (Savulescu 2001, 
Martens et al. 2006).  In fact, one-year survival rates following kidney 
transplantation have shown that IDD per se does not affect the likelihood of post-
transplantation complications or poor outcomes (Martens et al. 2006).  The 
collection and use of additional information of this nature for the middle and later 
years of life will thus be very important in formulating and addressing ethical 
questions. 
The recent recommendation that, irrespective of maternal age, all pregnancies in 
the U.S.A. should be screened for Down syndrome (ACOG 2007) is of equal 
significance.  Not surprisingly, this recommendation has met with resistance from 
the National Down Syndrome Society, which has urged that expectant mothers 
should not be unduly influenced either to undergo prenatal testing for the condition 
or to terminate a pregnancy if a positive diagnosis is received (NDSS 2007). 
Particular problems faced by indigenous and migrant communities 
Major problems may be encountered in accurately defining the levels of IDD in 
the indigenous populations of developed countries, given the overall lack of credible 
and representative disease prevalence data, and failure to accurately identify 
individuals of indigenous origin in many key data sets (Glasson et al. 2005, AIHW 
2007). Despite these qualifications, indigenous people are frequently over-
represented in IDD studies (Glasson et al. 2005), a finding that is most readily 
explained by social and economic disadvantage and degraded physical environments 
(Najman et al. 1992, Durkin 2002). 
In Europe, these types of problems are exemplified by the estimated 12 million 
Roma whose distribution across the continent, semi-itinerant lifestyle, and 
endogamous and often consanguineous marriage structure (Bittles 2000) complicate 
data collection and analysis.  All available data point to poorer living conditions, low 
literacy, and lower health standards and life expectancy among the Roma, with high 
rates of IDD.  However, their close family and clan networks mean that strong Ageing in people with intellectual disability 
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support mechanisms are available within the Roma community.  Despite similar 
social advantages, a study of the Irish Travellers, a genetically distinct indigenous 
community analogous to the Roma, showed high overall levels of ill-health, and 
average life expectancies which were almost 10 and 12 years less for men and 
women respectively than for the general Irish population (Barry et al. 1989). 
The recent widespread migration of ethnically diverse communities into Europe 
also merits monitoring, especially since attention has been drawn to a higher 
prevalence of IDD in some of these groups (Fernell 1998, Mitchell et al. 1998).  
Many migrant communities, such as Maghrebians in France, Belgium and the 
Netherlands, Turks and Kurds in Germany, and Pakistanis in the U.K. traditionally 
favour consanguineous marriage, and as a result higher levels of IDD would be 
expected due to the expression of detrimental recessive genes (Bittles 2001, Bittles 
2003).  Given the sensitivity of the subject, and the young age profiles of most 
immigrant communities in Europe, reliable information is not yet available on the 
potential scale of the problems that might ensue.  However, as with the Roma, the 
strongly cohesive social structure that is characteristic of a large majority of migrant 
communities should prove beneficial in caring for community members with IDD as 
they age. 
Conclusions 
The global trend of continued integration of people with IDD into the community 
has important implications in terms of the resources that are needed to provide 
services appropriate to their needs, and also meet the requirements of their families 
and carers.  Advice in successfully navigating local and national health systems, 
ethical decisions that are associated with care, and positive general attitudes from the 
government, business sector and the wider community are all needed to support 
these processes.  Although some improvement has already occurred, further focus on 
closing the gaps in health and wellbeing that exist between individuals with IDD and 
the general public is required, via the opening of new health care channels and the 
development of appropriate systems to adequately cater for the needs of people with 
IDD as they age.  Under these circumstances the health targets set by the World 
Health Organization for people with IDD can become a reality, allowing all 
Europeans to be included in a Healthy Ageing future.  
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